Metrics to compare | 600538 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600538PeersSector | |
|---|---|---|---|---|
P/E Ratio | −31.6x | −23.5x | 3.2x | |
PEG Ratio | −2.90 | 0.00 | 0.00 | |
Price/Book | 4.6x | 3.0x | 1.6x | |
Price / LTM Sales | 9.4x | 2.5x | 1.3x | |
Upside (Analyst Target) | - | 2.6% | 38.5% | |
Fair Value Upside | Unlock | −10.7% | 2.5% | Unlock |
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, distributes pharmaceutical products in China. It operates through Pharmaceutical Distribution; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails pharmaceutical products through hospitals, clinics, other medical institutions, pharmacies, health centers, clinics, directly operated stores, general agents, distributors, and allocations. It also provides pearl eye drops, pearl powder, and pearl layer powder under the Haibao brand; brand gastrointestinal granules, honeysuckle oral solution, and children's syrup under the Guofa brand; and traumatic injury medicated wine, and sea snake medicated wine under the Haima brand. In addition, the company produces and sells forensic DNA testing equipment, reagents, and consumables; and provides technical services, including DNA testing services. Further, it engages in culture and arts activities; and provision of technical services. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beihai Gofar Chuanshan Biological Co., Ltd. in June 2021. Beihai Gofar Chuanshan Biological Co., Ltd. was incorporated in 1993 and is headquartered in Beihai, China.